Trials

In this section you will find planned, ongoing and completed paediatric clinical trials with the contribution of GermanNetPaeT.

c4c non-industry / academic "Proof-of-Viability" trials

 

Steroids to Treat Kawasaki Disease: KD-CAAP will assess the effectiveness of adding steroids to standard treatment in children with Kawasaki Disease, and aims to recruit 262 children as part of the study (Leads: Dr. Despina Eleftheriou and Prof Paul Brogan of the University College of London (UCL), an academic research institution in the UK).

For more information about the research study, contact: Despina Eleftheriou d.eleftheriou@ucl.ac.uk

 

Paracetamol in Premature Babies: TREOCAPA will assess the effectiveness of paracetamol in premature babies with a patent ductus arteriosus, and aims to recruit around 600 babies as part of the study (Lead: Prof. Jean-Christophe Roze of INSERM, a public research organization in Paris, France entirely dedicated to human health)

For more information about the research study, contact: Jean Christophe Roze jcroze@chu-nantes.fr

 

https://conect4children.org/news/press-release-launch-of-the-non-industries-study/

Contribution of German study centres

KD-CAAP: Steroids to Treat Kawasaki Disease